Theaflavins retard human breast cancer cell migration by inhibiting NF-κB via p53-ROS cross-talk

FEBS Letters

Volumn 584, Issue 1, 2010, Pages 7-14

  Adhikary, Arghya ^a   Mohanty, Suchismita ^a   Lahiry, Lakshmishri ^a   Hossain, Dewan Md Sakib ^a   Chakraborty, Samik ^a   Das, Tanya ^a  

^a BOSE INSTITUTE   (India)

Author keywords

Breast cancer; Migration; NF B; p53; Reactive oxygen species; Theaflavins

Indexed keywords

GELATINASE A; GELATINASE B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SYNAPTOTAGMIN I; THEAFLAVIN;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; METASTASIS INHIBITION; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTIOXIDANTS; BIFLAVONOIDS; BREAST NEOPLASMS; CARCINOMA; CATECHIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM METASTASIS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 71549169241     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.10.081     Document Type: Article

References (42)

1. Lahiry L., Saha B., Chakraborty J., Bhattacharyya S., Chattopadhyay S., Banerjee S., Choudhuri T., Mandal D., Bhattacharyya A., Sa G., and Das T. Contribution of p53-mediated Bax transactivation in theaflavin-induced mammary epithelial carcinoma cell apoptosis. Apoptosis 13 (2008) 771-781
2. Isemura M., Saeki K., Kimura T., Hayakawa S., Minami T., and Sazuka M. Tea catechins and related polyphenols as anti-cancer agents. Biofactors 13 (2000) 81-85
3. Junk D.J., Vrba L., Watts G.S., Oshiro M.M., Martinez J.D., and Futscher B.W. Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells. Neoplasia 10 (2008) 450-461
4. Ostrakhovitch E.A., and Cherian M.G. Role of p53 and reactive oxygen species in apoptotic response to copper and zinc in epithelial breast cancer cells. Apoptosis 10 (2005) 111-121
5. Fini M.A., Orchard W.D., Kosmider B., Amon J.D., Kelland R., Shibao G., and Wright R.M. Migratory activity of human breast cancer cells is modulated by differential expression of xanthine oxidoreductase. J. Cell. Biochem. 105 (2008) 1008-1026
6. Bragado P., Armesilla A., Silva A., and Porras A. Apoptosis by cisplatin requires p53 mediated p38a MAPK activation through ROS generation. Apoptosis 12 (2007) 1733-1742
7. Rivera A., and Maxwell A.S. The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. J. Biol. Chem. 280 (2005) 29346-29354
8. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., and Vogelstein B. A model for p53 induced apoptosis. Nature 389 (1997) 300-305
9. Biswas D.K., Shi Q., Baily S., Strickland I., Ghosh S., Pardee A.B., and Iglehard J.D. NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc. Natl. Acad. Sci. 101 (2004) 10137-10142
10. Cogswell P.C., Guttridge D.C., Funkhouser W.K., and Baldwin A.S. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3. Oncogene 19 (2000) 1123-1131
11. Zhang L., Chen W., and Li X. A novel anticancer effect of butein: inhibition of invasion through the ERK1/2 and NF-kappa B signaling pathways in bladder cancer cells. FEBS Lett. 582 (2008) 1821-1828
12. Wu J.M., Sheng H., Saxena R., Skill N.J., Bhat-Nakshatri P., Yu M., Nakshatri H., and Maluccio M.A. NF-kappaB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy. Cancer Lett. 278 (2009) 145-155
13. Kawauchi K., Araki K., Tobiume K., and Tanaka N. Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetylglucosamine modification. Proc. Natl. Acad. Sci. 106 (2009) 3431-3436
14. Wu M., Bian Q., Liu Y., Fernandes A.F., Taylor A., Pereira P., and Shang F. Sustained oxidative stress inhibits NF-kappaB activation partially via inactivating the proteasome. Free Radic. Biol. Med. 46 (2009) 62-69
15. Shukla S., and Gupta S. Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation. Free Radic. Biol. Med. 44 (2008) 1833-1845
16. Sa G., and Fox P.L. Basic fibroblast growth factor-stimulated endothelial cell movement is mediated by a pertussis toxin-sensitive pathway regulating phospholipase A2 activity. J. Biol. Chem. 269 (1994) 3219-3225
17. Das T., Sa G., Paszkiewicz-Kozik E., Hilston C., Molto L., Rayman P., Biswas K., Kudo D., Bukowski R.M., Finke J.H., and Tannenbaum C. Tumors induce T cell apoptosis through receptor-dependent and receptor-independent pathways. J. Immunol. 180 (2008) 4687-4696
18. Das T., Sa G., Hilston C., Kudo D., Rayman P., Biswas K., Molto L., Bukowski R., Rini B., Finke J.H., and Tannenbaum C. GM1 and TNF, overexpressed in renal cell carcinoma, synergize to induce T cell apoptosis. Cancer Res. 68 (2008) 2014-2023
19. Mandal D., Bhattacharyya S., Lahiry L., Chattopadhyay S., Sa G., and Das T. Black tea-induced decrease in IL-10 and TGF- of tumor cells promotes Th1/Tc1 response in tumor-bearer. Nutr. Cancer 58 (2007) 213-221
20. Bhattacharyya S., Mandal D., Saha B., Sen G.S., Das T., and Sa G. Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction. J. Biol. Chem. 282 (2007) 15954-15964
21. Bhattacharyya S., Mandal D., Sen G.S., Pal S., Banerjee S., Lahiry L., Finke J.H., Tannenbum C.S., Das T., and Sa G. Tumor-induced oxidative stress perturbs NFκB activity augmenting TNFα-mediated T cell death: protection by curcumin. Cancer Res. 67 (2007) 362-370
22. Bhattacharyya A., Lahiry L., Mandal D., Sa G., and Das T. Black tea induces tumor cell apoptosis by Bax translocation, loss in mitochondrial transmembrane potential, cytochrome c release and caspase activation. Int. J. Cancer 117 (2005) 308-315
23. Choudhuri T., Pal S., Das T., and Sa G. Curcumin selectively induces apoptosis in deregulated cyclin D1 expressed cells at G2 phase of cell cycle in a p53-dependent manner. J. Biol. Chem. 280 (2005) 20059-20068
24. Sanklpal N.V., Willman M.W., Fleming T.P., Mayfield J.D., and Gillanders W.E. Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion. Cancer Res. 69 (2009) 753-757
25. Hsu S.C., Yang J.S., Kuo C.L., Lo C., Lin J.P., Hsia T.C., Lin J.J., Lai K.C., Kuo H.M., Huang L.J., Kuo S.C., Wood W.G., and Chung J.G. Novel quinolone CHM-1 induces apoptosis and inhibits metastasis in a human osterogenic sarcoma cell line. J. Orthop. Res. (2009) (Epub ahead of print)
26. Sablina A.A., Budanov A.V., Ilyinskaya G.V., Agapova L.S., Kravchenko J.E., and Chumakov P.M. The antioxidant function of the p53 tumor suppressor. Nat. Med. 11 (2005) 1306-1313
27. Liu Z., Lu H., Shi H., Du Y., Yu J., Gu S., Chen X., Liu K.J., and Hu C.A. PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells. Cancer Res. 65 (2005) 1647-1654
28. Dhar S.K., Xu Y., Chen Y., and Clair D.K. Specificity protein 1-dependent p53-mediated suppression of human manganesesuperoxide dismutase gene expression. J. Biol. Chem. 281 (2006) 21698-21709
29. Liu B., Chen Y., and St. Clair D.K. ROS and p53: a versatile partnership. Free Radic. Biol. Med. 44 (2008) 1529-1535
30. Bertout J.A., Majmundar A.J., Gordan J.D., Lam J.C., Ditsworth D., Keith B., Brown E.J., Nathanson K.L., and Simon M.C. HIF2{alpha} inhibition promotes p53 pathway activity, tumor cell death, and radiation responses. Proc. Natl. Acad. Sci. USA 106 (2009) 14391-14396
31. She Q.B., Chen N., and Dong Z. ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation. J. Biol. Chem. 275 (2000) 20444-20449
32. Shao J., Fujiwara T., Kadowaki J., Fukazawa T., Waku T., Itoshima T., Yamatsuji T., Nishizaki M., Roth J.A., and Tanaka N. Overexpression of the wild-type p53 gene inhibits NF-kB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells. Oncogene 19 (2000) 726-736
33. Liu J., Zhan M., Hannay J.A.H., Das P., Bolshakov S.V., Kotilingam D., Yu D., Lazar A.F., Pollock R.E., and Lev D. Wild-type p53 inhibits nuclear factor-kB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis. Mol. Cancer Res. 4 (2006) 803-810
34. Gloire G., Legrand-Poels S., and Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 72 (2006) 1493-1505
35. 1 adenosine receptor expression by activating nuclear factor kB. Mol. Pharmacol. 53 (1998) 663-669
36. Wu M., Bian Q., Liu Y., Fernandes A.F., Taylor A., Pereira P., and Shang F. Sustained oxidative stress inhibits NF-κB activation partially via inactivating the proteasome. Free Radic. Biol. Med. 46 (2009) 62-69
37. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18 (2000) 621-663
38. Kawauchi K., Araki K., Tobiume K., and Tanaka N. Activated p53 induces NF-kappaB DNA binding but suppresses its transcriptional activation. Biochem. Biophys. Res. Commun. 372 (2008) 137-141
39. Sliva D., Rizzo M.T., and English D. Phosphatidylinositol 3′-kinase and NF-kB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator (uPA). J. Biol. Chem. 277 (2002) 3150-3157
40. Shukla S., MacLennan G.T., Fu P., Patel J., Marengo S.R., Resnick M.I., and Gupta S. Nuclear factor-κB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia 6 (2004) 390-400
41. Kim A., Kim M.J., Yang Y., Kim J.W., Yeom Y.I., and Lim J.S. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells. Carcinogenesis 30 (2009) 927-936
42. Yeh M.H., Kao S.T., Hung C.M., Liu C.J., Lee K.H., and Yeh C.C. Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells. Toxicol. Lett. 184 (2009) 204-210